Methionine sulfoxide reductase B3 (MsrB3) is a protein repair enzyme that specifically reduces methionine-R-sulfoxide to methionine. A recent genetic study showed that the MSRB3 gene is associated with autosomal recessive hearing loss in human deafness DFNB74.
INTRODUCTION
The cochlea (the auditory portion of the inner ear) plays a vital role in the conversion of physical vibrations generated by sound waves into chemical signals in the process of hearing.
The mammalian cochlea contains approximately 16,000 sensory hair cells that are arranged as three rows of outer hair cells (OHCs) and one row of inner hair cells (IHCs) (1) (2) . Because these hair cells cannot be regenerated during the lifetime of an animal, damage to or loss of hair cells due to various factors, such as genetic defects, noise, and drugs, is irreversible and leads to permanent hearing loss (3) .
Methionine is one of the most sensitive amino acids to oxidation by reactive oxygen species (ROS). The oxidation of methionine generates a diastereomeric mixture of methionine-R-sulfoxide and methionine-S-sulfoxide (4) , which may cause significant changes to protein structure and function (5) (6) . However, oxidized methionine can be repaired using the enzyme methionine sulfoxide reductase (Msr) . Two families of Msrs, MsrA and MsrB, have evolved to catalyze the stereospecific reduction of methionine sulfoxide to methionine in proteins (7) (8) (9) . MsrA is specific for the S-form of methionine sulfoxide, whereas MsrB only reduces the R-form (10) (11) . The functions of Msrs are to repair oxidatively damaged proteins, to protect against oxidative stress, and to regulate protein function.
In mammals, three genes encode MsrB proteins (MsrB1, 2, and 3, which have different subcellular locations), whereas a single gene encodes MsrA (12) (13) (14) . MsrB1 is a cytosolic and nuclear selenoenzyme, MsrB2 is targeted to the mitochondria, and MsrB3 exists in two forms in humans, MSRB3A and MSRB3B, which contain different N-terminal regions generated via alternative first exon splicing. MSRB3A is targeted to the endoplasmic reticulum (ER), whereas MSRB3B resides in the mitochondria (13) . However, no evidence for the existence of alternatively spliced MsrB3 forms in mice has been reported. Instead, mouse MsrB3 contains consecutive ER and mitochondrial signal peptides in the N-terminal region and is by guest on November 7, 2016 http://hmg.oxfordjournals.org/ Downloaded from targeted to the ER (15) .
Recently, Ahmed et al. reported that the MSRB3 gene is associated with human DFNB74, a locus for autosomal recessive hearing loss (16) . Two mutations in MSRB3, one missense and one nonsense mutation, were identified in families with the DFNB74 locus. The missense mutation (p.Cys89Gly) is a loss-of-function allele that results in a complete lack of MSRB3 enzymatic activity. The nonsense mutation (p.Arg19X) occurs in the mitochondrial targeting sequence of MSRB3B. These data suggest that functional MSRB3 is essential for hearing in humans (16) . However, the lack of animal models for MsrB3 deficiency has hindered our understanding of the function of MSRB3 and the pathogenesis of DFNB74 hearing loss.
Here, we present the first report of the generation and evaluation of MsrB3 knockout mice as an animal model for DFNB74 and propose a possible pathological mechanism leading to hearing loss caused by MSRB3 deficiency in DFNB74 patients.
RESULTS

Generation of MsrB3 knockout mice
In mice, the MsrB3 gene is located on chromosome 10 and comprises approximately 120 kb of genomic DNA. MsrB3 knockout mice were generated using homologous recombination.
The knockout construct was designed to replace exon 7 encoding the catalytic Cys residue with a Neo cassette (Fig. 1A) ; correct gene targeting was verified with Southern blot analysis (Supplementary material, Fig. S1 ).
In homozygous MsrB3
−/− mice, the MsrB3 protein was not detected in the heart, skeletal muscle, or testis, tissues in which MsrB3 proteins are highly expressed in wild type mice (Fig. 5 MsrB3 knockout mice. MsrB1 levels were higher in the heart and skeletal muscle in
MsrB3
−/− mice than in MsrB3 +/+ mice (Fig. 1B) . MsrB2 was expressed at similar levels in the heart but at slightly decreased levels in the skeletal muscle and testis. The levels of MsrA did not differ in any of the tissues examined (Fig. 1B) .
MsrB3 knockout mice are deaf
Because the MSRB3 gene is associated with DFNB74 deafness in humans (16), we sought to ascertain whether the MsrB3 knockout mice also exhibited a hearing impairment phenotype.
We measured the hearing thresholds using an auditory brainstem response (ABR) test in 
MsrB3 is expressed in the sensory epithelia of cochlear and vestibular tissues
MsrB3 expression was analyzed immunohistochemically in mouse inner ears from embryonic day (E) 12.5 to P18. The inner ear sections contained both the cochlea and vestibular end organs including the cochlear duct, utricle, saccule, and crista ampullaris. No detectable 6 expression began to be detected at E13.5 in the sensory epithelia of vestibular organs, such as the maculae of the utricle, saccule, and all three cristae ( Fig. 3J and data not shown). MsrB3 expression in the cochlea was not detected until E15.5, at which point MsrB3 signals were found primarily in the basal and middle turns of the cochlea, and later in all cochlear turns (Fig. 3D ). These temporal and spatial expression patterns of MsrB3 follow the sequence of inner ear hair cell differentiation. The MsrB3 signals in the cochlea and vestibule were continuously detected until at least P18, when the mouse hearing ability matures ( ) and MsrB3 −/− mice. Together, these data suggest that MsrB3 deletion has no effect on protein oxidation in inner ear tissues. 
The stereocilia of inner ear hair cells progressively degenerate in
Deletion of MsrB3 leads to apoptotic cell death in the organ of Corti
We next examined whether stereociliary degeneration is associated with hair cell loss in 
DISCUSSION
Reduction and oxidation (redox) homeostasis is essential in almost all living organisms to delicately control the balance between the beneficial and harmful effects of free radicals by guest on November 7, 2016 http://hmg.oxfordjournals.org/ Downloaded from such as ROS and reactive nitrogen species (RNS). The deleterious actions of these free radicals have been associated with the pathogenesis of a variety of diseases including cancer, diabetes mellitus, inflammatory diseases, neurodegenerative disorders, and aging (17) . A recent report demonstrating genetic mutations in the MSRB3 gene as a cause of prelingual hearing loss in DFNB74 patients also strongly suggested a crucial role of redox homeostasis in the development or functioning of the inner ear (16) .
To explore the pathophysiological mechanisms of deafness caused by the null alleles of MSRB3, we generated MsrB3 −/− mice. Similar to the phenotypes observed in the DFNB74
patients (16) 
MATERIALS AND METHODS
Generation of MsrB3 knockout mice
The MsrB3 knockout-targeting construct was designed to abolish exon 7 within the gene by replacing this exon with a neomycin resistance gene. Exon 7 harbors the active site of the enzyme, including the catalytic Cys residue. To clone the 5' left arm, a first 1,509-bp (LA1) fragment, a second 2,778-bp (LA2) fragment downstream of LA1, and a third 3003-bp (LA3) fragment downstream of LA2 were amplified using PCR from 129/SvJ mouse genomic DNA and inserted into the NotI/NheI, NheI/XhoI, and XhoI/SalI sites, respectively, in the pDrive cloning vector. A 2,681-bp fragment (RA) coding for the 3' right arm was amplified using PCR and inserted into the SalI/NheI sites in the pDrive cloning vector. All cloned fragments were verified using DNA sequencing. The LA1 fragment containing the NotI/NheI sites was then ligated to the same sites of pDrive containing LA2. The MsrB3 knockout construct was prepared as follows: The RA fragment containing the SalI/NheI sites was cloned into the XhoI/NheI sites of the pOSDupDel-Neo vector. The LA3 fragment containing the XbaI/SalI sites was then cloned into the same sites of pOSDupDel containing the RA fragment. The LA1/2 fragment containing the NotI/XhoI sites was then cloned into the same sites of pOSDupDel containing the RA and LA3 fragments. The targeting construct contained a 7.69-kb 5' left arm, a 1.3-kb neomycin cassette, and a 2.68-kb 3' right arm. We electroporated 129/SvJ embryonic stem (ES) cells with the targeting construct after it had been linearized using NotI. Positive recombinant ES cells were identified using PCR and then microinjected into C57BL/6 blastocysts. The resulting chimeric mice were then mated with C57BL/6 mice.
Germ line transmission was confirmed using Southern blot analysis (Supplementary Material, Fig. S1 ). Genomic DNA was digested with SphI and then probed with a 651-bp 3' probe. The knockout allele yielded a 5.1-kb band, whereas the wild type allele generated a 6.9-kb band.
Animal preparation and experiments
All mice used in the animal experiments were obtained by breeding heterozygous MsrB3 knockout mice of a 129/SvJ and C57BL/6 mixed background. The mouse genotypes were confirmed using PCR analysis. The animal experiments were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee of Kyungpook National University and Yeungnam University.
Mice genotyping
Genomic DNA was isolated from mouse tails. PCR genotyping was performed using the following primers: one forward primer (5'-CAAAGTCTGTCTGGAGCCATC-3') and two reverse primers for the wild type (5'-AGAACTGCCATCTAGACGAGAGAG-3') and knockout (5'-GATGATCTCGTCGTGACCCATG-3') alleles. The PCR products were 538 bp for the wild type allele and 393 bp for the knockout allele.
Auditory brainstem response
The animals were intramuscularly anesthetized using a mixture of tiletamine-zolazepam (1.8 mg/100 g) and xylazine hydrochloride (0.7 mg/100 g). Body temperature was monitored using a rectal thermometer, and the animals were maintained on a heating pad at 37°C. All experiments were performed in a soundproof room. Sound-evoked ABRs were measured using a Tucker Davis Technology (TDT) system as previously described (31). Briefly, needle electrodes from the head stage (RA4LI, TDT) were connected to a pre-amplifier (RA4PA, TDT) to record ABRs and inserted into the vertex (+ charge), mastoid (− charge), and hind leg (ground). Acoustic stimuli were calibrated at 90 dB SPL (sound pressure level) with 8, 16, and 32 kHz tone bursts using calibration software (SigCalRP) in TDT System 3 and the probe microphone system. Tone burst stimuli with a 1-ms rise/fall and a 5-ms plateau or transient click stimuli at frequencies of 8, 16 , and 32 kHz were generated using signal design software (SigGenRP) and applied. The signals needed for the stimuli were generated using SigGenRP and an RP2.1 real-time processor and then transmitted in sequence through a programmable attenuator (PA5, TDT), speaker driver (ED1, TDT), and electrostatic speaker (EC1, TDT).
Stimuli were generated every 36.1 ms for 500 repetitions from 90 dB SPL to the acoustic threshold in 5-dB decrements at every frequency. The phase of the stimuli was reversed after each stimulus to reduce noise caused by repetitive stimuli.
MsrB3 antibody
Four different polyclonal anti-MSRB3 antibodies were tested and their specificities were compared: two new antisera prepared by immunizing rabbits with a recombinant human MSRB3A, a rabbit polyclonal antiserum against human MSRB3 (as previously described (15)), and a rabbit polyclonal anti-human MSRB3 obtained from Sigma-Aldrich. To validate specificity against mouse MSRB3, we performed Western blotting and immunohistochemistry analyses using MsrB3 +/− and MsrB3 −/− mouse tissues and cells transfected with a mouse MsrB3-GFP fusion construct (15) . Among the evaluated antibodies, the previously described anti-human MSRB3 antibody (15) exhibited the highest specificity for mouse MsrB3 (Supplementary Material, Fig. S4 and S12). Thus, this antibody was used for further study.
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Frozen-section immunohistochemistry
Inner ears were isolated from E12.5, E13.5, E14.5, E15.5, and E18.5, as well as P0 and P18 mice and fixed with 4% paraformaldehyde in phosphate buffered saline (PBS) for 1 day at 4°C. The inner ears from P18 mice were then decalcified in 10% ethylenediaminetetraacetic acid in PBS for 2 days at 4°C. All tissues were dehydrated with 30% sucrose in PBS and a 
Whole-mount immunostaining
Inner ears were isolated from P6 and P15 MsrB3 +/+ mice and P5 and P13 MsrB3 +/− and
MsrB3
−/− mice; the ears were rapidly fixed by infusion with 4% paraformaldehyde in PBS via the round window and immersed in the same fixative solution at 4°C for 1 h. After fixation, the organ of Corti and vestibule were dissected using a dissecting microscope. The dissected samples were immunostained with an anti-Msr3B antibody following the immunostaining procedure described above. Next, F-actin was labeled by incubation with Alexa Fluor 488 phalloidin (Molecular Probes/Invitrogen). After mounting in Fluoromount (Sigma-Aldrich), the samples were visualized using a confocal laser scanning microscope (LSM700, Carl Zeiss) and the ZEN 2009 program.
Scanning electron microscopy
Cochleas were immediately isolated from the euthanized mice and perfused carefully through the round window using 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) after a hole was made at the top of the cochlea. The perfused cochleas were immersed in the same fixation mixture for 1 h at room temperature. The lateral wall, Reissner's membrane, and the tectorial membrane were removed via dissection under a dissecting microscope and fixed overnight at 4°C in 0.1 M sodium cacodylate buffer (pH 7.4) containing 2.5% glutaraldehyde, 2 mM calcium chloride, and 3.5% sucrose. After fixation, the dissected specimens were rinsed three times for 20 min at 4°C with 0.1 M sodium cacodylate buffer containing 2 mM calcium chloride. The specimens were treated postfixation using the osmium tetroxide (OsO 4 )-thiocarbohydrazide method developed by . Briefly, specimens were immersed in 1% OsO 4 for 1 h at 4°C and then placed in saturated thiocarbohydrazide for 20 min at room temperature. This specimen treatment was repeated three times at room temperature. The specimens were then dehydrated using a graded series of ethanol solutions, dried using a critical point drier (HCP-2, Hitachi), affixed on a stub, and coated with platinum using a sputter coater (E1030, Hitachi). The coated specimens were mounted on a stub holder and viewed using a cold-field emission scanning electron microscope (S-4300, Hitachi) operated at 15 kV.
Transmission electron microscopy
For ultra-thin sectioning, the temporal bones were rapidly removed and fixed in 2.5%
glutaraldehyde and 2% paraformaldehyde in 1X PBS (pH 7.4) for 24 h. After fixation, the samples were decalcified in 0.2 M EDTA (pH 7.4) with 2.5% glutaraldehyde and 2%
paraformaldehyde at 4°C for two weeks and then post-fixed using osmium tetroxide ( OsO 4 ) for 30 min. The specimens were rinsed three times in 0.1 M cacodylate buffer at 4°C and then dehydrated using a graded series of ethanol solutions. To remove residual ethanol, the dehydrated specimens were treated twice with propylene oxide at room temperature. Then, the specimens were placed in capsule caps filled with fresh Epon resin and incubated overnight at 65°C. Ultra-thin sections (60 nm) were obtained with a Leica Ultracut UCT ultramicrotome (Leica Microsystems) using a diamond knife (Diatome) and collected on 15 nickel grids (400 mesh). Grids were examined on a transmission electron microscope (H-7500, Hitachi).
Histological analysis
Inner ears were isolated from P20 mice and fixed with 4% paraformaldehyde in PBS for 1 day at 4°C. After fixation, the inner ears were decalcified in 10% ethylenediaminetetraacetic acid in PBS for 2 days at 4°C. The samples were then dehydrated using a series of ethanol solutions, cleared in xylene, and embedded in paraffin. Five-micrometer sections were cut on a RM2125 RT microtome (Leica Microsystems) and stained with hematoxylin and eosin (H&E).
TUNEL assay and active caspase 3 detection
Cochlear sections obtained from P20 MsrB3 +/− and MsrB3 −/− mice were prepared as described above. The TUNEL assay was performed using an In Situ Cell Death Detection Kit 
Msr enzyme assay
The Msr enzyme assay used protein from the whole otic capsule including both whole membranous and bony labyrinth of 
Analysis of methionine sulfoxide levels
The tissues used in the Msr enzyme assay were homogenized in a lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 10% glycerol, and 1% 2-mercaptoethanol including Protease Inhibitor Cocktail Set 1 (Calbiochem). Supernatants were obtained via centrifugation. Protein concentrations were determined using a BCA protein assay kit (Thermo Fisher Scientific). The hydrogen peroxide (H 2 O 2 )-treated samples were also incubated in 100 mM H 2 O 2 for 2 h at 37°C in the presence of 2% SDS to inhibit peroxidase activity. The protein samples were resolved using 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE). The levels of methionine sulfoxide in the proteins were determined using a methionine sulfoxide immunoblotting kit (Cayman Chemical).
Measurement of carbonylated proteins
Carbonylated protein levels in the tissues used in the Msr enzyme assay were measured using the Oxyblot kit (Chemicon) according to the manufacturer's instructions. The blots were quantitatively analyzed using ImageJ software. 
